Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use
Open Access
- 18 June 2026
- journal article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70146
Abstract
Prior surveys of chronic automated red blood cell exchange (RCE) for patients with sickle cell disease (SCD) have identified considerable procedural variability, especially with the use of isovolemic hemodilution red blood cell exchange (IHD‐RCE). We conducted a survey of chronic RCE practices among American Society for Apheresis (ASFA) members to identify opportunities for practice harmonization and future studies. The ASFA SCD Research Subcommittee developed a 72‐item survey of chronic RCE practices, with a focus on IHD‐RCE. The survey was validated internally and distributed by email to all ASFA members from September 2024 to February 2025. One survey response from each institution was retained for data analysis. Descriptive statistics were performed. Sixty‐two survey responses, including three from international institutions, were retained for analysis. Sixty‐one percent of respondents (38/62) reported using at least one fixed RCE target, with end hematocrit being the most common fixed parameter (40%, 25/62), followed by fraction of cells remaining (31%, 19/62) and hemoglobin S% (27%, 17/62). Most respondents (60%, 37/61) performed IHD‐RCE at their institution, though other details such as the minimum hematocrit, exclusion criteria, and response to adverse effects were variable. Consistent pre‐ and post‐RCE laboratory monitoring practices were reported. Consistent with earlier surveys, procedural variability in chronic RCE practices for patients with SCD is observed. This highlights opportunities to compare outcomes where practice variability exists. Consensus guidelines based on institutional practices with optimal outcomes should be developed.Keywords
This publication has 31 references indexed in Scilit:
- Management of Patients with Sickle Cell Disease Using Transfusion TherapyHematology/Oncology Clinics of North America, 2016
- Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell AnemiaNew England Journal of Medicine, 2014
- Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadPediatric Blood & Cancer, 2011
- Advantages of isovolemic hemodilution‐red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patientsJournal of Clinical Apheresis, 2011
- Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell diseaseAmerican Journal of Hematology, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler UltrasonographyNew England Journal of Medicine, 1998
- Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.1994
- Effects of transfusion on rheological properties of blood in sickle cell anemiaTransfusion, 1982
- Abnormal rheology of oxygenated blood in sickle cell anemiaJournal of Clinical Investigation, 1970